Renovorx announces proposed public offering

Mountain view, calif.--(business wire)--renovorx, inc. (“renovorx” or the “company”) (nasdaq: rnxt), a life sciences company developing novel targeted oncology therapies and commercializing renovocath®, a novel, fda-cleared delivery platform, today announced that it has commenced an underwritten public offering of shares of its common stock or pre-funded warrants to purchase shares of common stock. all of the securities to be sold in the proposed offering will be offered by renovorx. the propos.
RNXT Ratings Summary
RNXT Quant Ranking